Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Vaccinia Virus Cell Surface-Binding Protein OPG105 (OPG105), N-His

Cat. No.VG9C373

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Vaccinia Virus Cell Surface-Binding Protein OPG105 (OPG105), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 32.2 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 32.2 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

The Vaccinia virus cell surface-binding protein OPG105 (also known as Carbonic Anhydrase Homolog) is crucial for the initial stages of viral infection. It binds to chondroitin sulfate on the cell surface, facilitating the attachment of the virus to host cells. In veterinary medicine, understanding the role of OPG105 can help in developing diagnostic tools to detect the presence of the virus and in designing strategies to prevent viral entry into host cells, thereby controlling the spread of the virus in animals.

Protein Vaccinia Virus Cell Surface-Binding Protein OPG105 (OPG105)
Protein Synonym Cell surface-binding protein OPG105; Carbonic anhydrase homolog; OPG105; D8L
UniProt ID P20508

Shipping and Storage

This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket